共 160 条
[1]
Alfano G(2018)Screening test of Fabry disease in patients with renal replacement therapy in the city of Modena G Ital Nefrol 35 1-13
[2]
Ganda N(2017)Fabry Disease in Southern Sardinia: epidemiological results from screening in an extensive area G Ital Nefrol 34 83-102
[3]
Cerami C(2017)Screening for Fabry disease among dialysis patients in Brazil: findings from the first 18 months of a Nationwide study Br J Med Med Res 21 1-16
[4]
Bolasco P(2007)The prevalence of Fabry’s disease among male patients on hemodialysis in Lithuania (a screening study) Medicina (Kaunas) 43 1-1743
[5]
Sitzia I(2009)Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations Nephrol Dial Transplant 24 1736-172
[6]
Murtas S(2016)Prevalence of Fabry disease among Turkish dialysis patients: data from hemodialysis centers in Bursa province Clin Nephrol 85 165-421
[7]
Coutinho M(2010)Serum globotriaosylceramide assay as a screening test for fabry disease in patients with ESRD on maintenance dialysis in Korea Korean J Intern Med 25 415-145
[8]
Neto O(2008)Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test Clin J Am Soc Nephrol 3 139-1329
[9]
Araújo J(2004)Results of a nationwide screening for Anderson-Fabry disease among dialysis patients J Am Soc Nephrol 15 1323-130
[10]
Maslauskienė R(2008)Implementation of high-throughput screening for Fabry disease in Toronto dialysis patients NDT Plus. 1 129-830